Questions discussed in this category
Are there any potency or effectiveness preferences that lead to that decision?
Considering the recent article in CHEST that describes the increasing incidence of fungal pneumonia Azar. Chest 2024
For example, anticoagulation for recent, significant PE or dual antiplatelet therapy for recent MI, but requiring urgent procedures such as biopsy of ...
If you prefer monitoring strategy, how frequently do you repeat labs and what is your referral thresholds to hepatology if you're practicing in primar...
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
Do you prescribe it universally or based on specific risk factors?
What should be ordered? Any medications given?
Are there situations in which you would continue the possible offending agent with close monitoring?
27444235802560824912270292353625675261592493526624264692491526081260842533223133119302491123705
Papers discussed in this category
Hepatology (Baltimore, Md.), 2012 Apr
Drug and alcohol dependence, 2024 Sep 07
JAMA psychiatry, 2025 Apr 01
JHEP reports : innovation in hepatology, 2024 Apr 10
Diabetes research and clinical practice, 2021 Mar 08
Journal of diabetes, 2025 Jun
Am J Respir Crit Care Med, 2019 Sep 1
Chest, 2023 Oct 07
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024 Mar 05
Physiological reports, 2019-05